Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05596500 · ClinicalTrials.gov registry record · NA

Blueberry-protein Supplementation and Exercise

A NA study, sponsored by Appalachian State University.

Completed
Registry status
NA
Development phase
21
Enrollment target

NCT05596500 is a NA study that has completed, run by Appalachian State University. The registered enrollment target is 21 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05596500, a NA study, has completed, sponsored by Appalachian State University.

COMPLETED
Registry status
NA
Development phase
21 participants
Enrollment target

Study Summary

This study is the human clinical trial component of an SBIR grant with Sinnovatek (funded). Cyclists (n=20) will consume a blueberry-protein, blueberry, or placebo supplement for 2 weeks prior to cycling for 2.5 h at high intensity. Washout periods (2 weeks) will separate the 3 trials, and the cyclists will crossover (randomized) to one of the two others supplements for 2 weeks, and then engage in additional 2.5 h cycling bouts. Blood and urine samples will be collected pre- and post-supplementation for each of the 3 trials. Blood samples will also be collected immediately after and 1.5h- and 24h-post-exercise. Blood samples will be analyzed for inflammation and oxidative stress outcomes. Urine samples will be analyzed for blueberry gut-derived phenolics.

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT Blueberry-protein gel
  • DIETARY_SUPPLEMENT Blueberry gel

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2023-01-15
Est. Completion 2023-06-01
Phase NA

Sponsor

Appalachian State University

37 total trials

What the Registry Record Tells You About NCT05596500

The ClinicalTrials.gov registry entry for NCT05596500 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Appalachian State University, which has 37 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.

NCT05596500 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05596500 about?

NCT05596500 is a clinical study titled "Blueberry-protein Supplementation and Exercise". This study is the human clinical trial component of an SBIR grant with Sinnovatek (funded). Cyclists (n=20) will consume a blueberry-protein, blueberry, or placebo supplement for 2 weeks prior to cycling for 2.5 h at high intensity. Washout periods (2 weeks) will separate the 3 trials, and the cycli...

What is the current status of trial NCT05596500?

This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2023-01-15. Estimated completion is 2023-06-01.

What interventions are being tested in trial NCT05596500?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Blueberry-protein gel (DIETARY_SUPPLEMENT), Blueberry gel (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT05596500?

This trial is sponsored by Appalachian State University, which has 37 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.